• Explore A Treatment Option to Improve Glycemic Control in Adults With T2D

  • Oct 23 2023
  • Duración: 42 m
  • Podcast

Explore A Treatment Option to Improve Glycemic Control in Adults With T2D  Por  arte de portada

Explore A Treatment Option to Improve Glycemic Control in Adults With T2D

  • Resumen

  • Explore a treatment option to improve glycemic control in adults with T2D and when you should consider using a GLP-1 RA. Join experts in T2D Aaron King, MD, Davida Kruger, MSN, APRN-BC, and Javier Morales, MD, as they review the disease state of T2D, the role of GLP-1 in glucose regulation, guidelines on early use of GLP-1 RAs in T2D treatment, as well as dosing, administration, and the monotherapy data of a once daily GLP-1 RA for T2D treatment.

    This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

    Faculty Presenters:

    Aaron King, MD
    Physician
    Baptist Health System Physician
    San Antonio, TX

    Davida F. Kruger, MSN, APRN‐BC, BC‐ADM
    Certified Nurse Practitioner
    A Henry Ford Health System,
    Division of Endocrinology, Diabetes,
    Bone and Mineral Disorders
    Detroit, MI

    Javier Morales, MD, FACP, FACE
    Associate Clinical Professor of Medicine
    Hofstra Northwell
    Huntington, NY

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Explore A Treatment Option to Improve Glycemic Control in Adults With T2D

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.